{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:56:01Z","timestamp":1790222161428,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"China Scholarship Council-University of Western Australia"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.bbadis.2014.05.034","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T19:48:01Z","timestamp":1401997681000},"page":"622-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Dermatomyositis, polymyositis and immune-mediated necrotising myopathies"],"prefix":"10.1016","volume":"1852","author":[{"given":"Yue-Bei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"Mastaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2014.05.034_bb0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0010","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/aws046","article-title":"Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1\u03b2-induced accumulation of \u03b2-amyloid and cell death","volume":"135","author":"Schmidt","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0015","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ajpath.2011.05.055","article-title":"Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-gamma signaling cascade in attacked versus nonattacked myofibers","volume":"179","author":"Ivanidze","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0020","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1212\/01.wnl.0000192129.65677.87","article-title":"Inflammatory, immune, and viral aspects of inclusion-body myositis","volume":"66","author":"Dalakas","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrrheum.2011.139","article-title":"Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis","volume":"7","author":"Robinson","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0045","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.11428","article-title":"Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells","volume":"50","author":"Page","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10067-009-1316-7","article-title":"Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis","volume":"29","author":"Kim","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11926-012-0242-x","article-title":"Interleukin-17 in inflammatory myopathies","volume":"14","author":"Tournadre","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0065","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3899\/jrheum.120555","article-title":"BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies","volume":"40","author":"Lopez De Padilla","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2011.05.013","article-title":"Pathogenesis and therapies of immune-mediated myopathies","volume":"11","author":"Dalakas","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0075","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","article-title":"Immune-mediated necrotising myopathy is characterized by a specific Th1-M1 polarized immune profile","volume":"181","author":"Preusse","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0080","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.59.8.1170","article-title":"Molecular profiles of inflammatory myopathies","volume":"59","author":"Greenberg","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0090","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0095","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0100","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy","volume":"60","author":"Niewold","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0105","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1002\/art.34659","article-title":"Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course","volume":"64","author":"Reed","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0110","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon beta is associated with type 1 interferon-inducible gene expression in dermatomyositis","volume":"70","author":"Liao","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0115","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e31821f440a","article-title":"Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies","volume":"76","author":"Cappelletti","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0120","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/art.38038","article-title":"Interferon-alpha induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis","volume":"65","author":"Balboni","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/gene.2011.61","article-title":"Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis","volume":"13","author":"Greenberg","year":"2012","journal-title":"Genes Immun."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0130","doi-asserted-by":"crossref","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2005.12.008","article-title":"Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future","volume":"16","author":"Dalakas","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ajpath.2013.06.003","article-title":"Overexpression of MHC class I in muscle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfolded protein response","volume":"183","author":"Freret","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-510X(89)90228-1","article-title":"Early ultrastructural alterations in adult dermatomyositis Capillary abnormalities precede other structural changes in muscle","volume":"94","author":"De Visser","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3899\/jrheum.110739","article-title":"Nicotinamide adenine dinucleotide tetrazolium reductase identifies microvasculature activation in muscle from adult patients with dermatomyositis","volume":"39","author":"Charles-Schoeman","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0160","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.23884","article-title":"Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis","volume":"58","author":"Grundtman","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mus.21651","article-title":"Vascular pathology in dermatomyositis and anatomic relations to myopathology","volume":"42","author":"Pestronk","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/annrheumdis-2012-201822","article-title":"Whole microvascular unit deletions in dermatomyositis","volume":"72","author":"Gitiaux","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005072-197501000-00005","article-title":"Dermatomyostis of childhood, ultrastructural alteratious of muscle and intramuscular blood vessels","volume":"34","author":"Banker","year":"1975","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0180","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/NEN.0b013e3182a7f0b8","article-title":"Skeletal muscle microvasculature in the diagnosis of neuromuscular disease","volume":"72","author":"Buckley","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/01913120802209379","article-title":"Tubuloreticular structures in different types of myositis: implications for pathogenesis","volume":"32","author":"Bronner","year":"2008","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0190","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.10140","volume":"46","author":"Englund","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0195","first-page":"638","article-title":"Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon","volume":"52","author":"Grimley","year":"1985","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0092-8674(00)81758-4","article-title":"The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities","volume":"95","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0205","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/BOR.0b013e328358bd85","article-title":"Myositis autoantibodies","volume":"24","author":"Casciola-Rosen","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0198-8859(91)90085-N","article-title":"Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501","volume":"32","author":"Reed","year":"1991","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0215","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/ar4207","article-title":"Implications in the difference of anti-Mi-2 and -p155\/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara","volume":"15","author":"Petri","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0220","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","article-title":"TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications","volume":"43","author":"Pachman","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0225","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","article-title":"Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women","volume":"60","author":"Love","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0230","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.38137","article-title":"Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders","volume":"65","author":"Miller","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0235","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","article-title":"Identification of a novel autoantibody reactive with 155 and 140kDa nuclear proteins in patients with dermatomyositis: an association with malignancy","volume":"46","author":"Kaji","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis","volume":"64","author":"Trallero-Araguas","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0250","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0255","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","article-title":"Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy","volume":"89","author":"Trallero-Araguas","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0260","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kD polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0270","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acr.21728","article-title":"Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody","volume":"64","author":"Cao","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0275","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/acr.21985","article-title":"Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0280","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0285","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","article-title":"The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody","volume":"49","author":"Nakashima","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0290","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","article-title":"Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis","volume":"51","author":"Gono","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0295","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","article-title":"Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum","volume":"65","author":"Hall","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0300","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kD protein in juvenile dermatomyositis are associated with calcinosis","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0305","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","article-title":"Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein","volume":"36","author":"Espada","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0310","first-page":"S139","article-title":"Clinical and serological characterization of the anti-MJ antibody in childhood myositis","volume":"40","author":"Oddis","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0315","first-page":"S787","article-title":"Sera with autoantibodies to the MJ antigen react with NXP2","volume":"56","author":"Targoff","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0320","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","article-title":"Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0325","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0330","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9629(15)40734-7","article-title":"Autoantibodies in inflammatory myopathies","volume":"319","author":"Garlepp","year":"2000","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0335","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00296-010-1637-5","article-title":"A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis","volume":"32","author":"Limaye","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0340","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/08916934.2012.755958","article-title":"Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients","volume":"46","author":"Muro","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0345","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","article-title":"Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis","volume":"68","author":"Betteridge","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0350","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3899\/jrheum.121168","article-title":"Low prevalence of anti-DFS70\/LEDGF antibodies in patients with dermatomyositis and other systemic autoimmune rheumatic diseases","volume":"40","author":"Muro","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0355","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1523-1747.2002.01869.x","article-title":"Associations of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis","volume":"119","author":"Werth","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0360","first-page":"148","article-title":"Association of tumor necrosis factor alpha (TNF-alpha) and interleukin 10 (IL-10) gene polymorphisms in dermatomyositis patients: a pilot study","volume":"20","author":"Hristova","year":"2012","journal-title":"Acta Dermatovenerol. Croat."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0365","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/art.23900","article-title":"The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients","volume":"58","author":"Chinoy","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0370","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1002\/art.34573","article-title":"Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity","volume":"64","author":"Wang","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0375","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddu077","article-title":"Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis","author":"Kwon","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0380","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.4049\/jimmunol.172.8.5041","article-title":"Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis?","volume":"172","author":"Reed","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0385","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/rheumatology\/40.11.1279","article-title":"Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies","volume":"40","author":"Artlett","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0390","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.0708115104","article-title":"Distinctive patterns of microRNA expression in primary muscular disorders","volume":"104","author":"Eisenberg","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0395","article-title":"Inhibition of myogenic MicroRNAs-1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies","author":"Georgantas","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0400","doi-asserted-by":"crossref","first-page":"345347","DOI":"10.1155\/2013\/345347","article-title":"Correlation between the frequency of Th17 Cell And The Expression of MicroRNA-206 in patients with dermatomyositis","volume":"2013","author":"Tang","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0405","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1002\/art.34606","article-title":"Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0410","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1684\/ejd.2013.1959","article-title":"Down-regulation of miR-223 contributes to the formation of Gottron's papules in dermatomyositis via the induction of PKCvarepsilon","volume":"23","author":"Inoue","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0415","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2340\/00015555-1459","article-title":"Decreased miR-7 expression in the skin and sera of patients with dermatomyositis","volume":"93","author":"Oshikawa","year":"2013","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0420","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.63.2.402","article-title":"Polymyositis: an overdiagnosed entity","volume":"63","author":"Miller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0425","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","article-title":"Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM","volume":"70","author":"Chahin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0430","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1212\/WNL.28.1.8","article-title":"Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy","volume":"28","author":"Carpenter","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0435","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.61.3.288","article-title":"Unicorns, dragons, polymyositis, and other mythological beasts","volume":"61","author":"Amato","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0440","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0445","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1157\/13113285","article-title":"Polymyositis-dermatomyositis: incidence in Spain (1997\u20132004)","volume":"129","author":"Vargas-Leguas","year":"2007","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0450","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","article-title":"Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study","volume":"165","author":"Kuo","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0455","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00296-010-1745-2","article-title":"Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak General Hospital","volume":"32","author":"Teh","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0460","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00415-011-6185-8","article-title":"Increase in number of sporadic inclusion body myositis (sIBM) in Japan","volume":"259","author":"Suzuki","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0465","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"Martin","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0470","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.nmd.2008.04.015","article-title":"Distal inflammatory myopathy: unusual presentation of polymyositis or new entity?","volume":"18","author":"Dimitri","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0475","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00296-011-1870-6","article-title":"Dropped head in polymyositis","volume":"32","author":"Toru","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0480","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/mus.21403","article-title":"Camptocormia as a presentation of generalized inflammatory myopathy","volume":"40","author":"Kuo","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0485","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/mus.21316","article-title":"Distal-symmetric focal inflammatory myopathy distinct from focal myositis and polymyositis","volume":"40","author":"Melzer","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0490","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/jnnp-2013-306573.205","article-title":"Camptocormia as a presentation of polymyositis","volume":"84","author":"Karsan","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0495","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.410230210","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies IV: cell-mediated cytotoxicity and muscle fiber necrosis","volume":"23","author":"Arahata","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0500","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0505","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1073\/pnas.0236183100","article-title":"Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis","volume":"100","author":"Hofbauer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0510","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.181.5.1863","article-title":"T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells","volume":"181","author":"Bender","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0515","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.20293","article-title":"Long-term persistence of clonally expanded T cells in patients with polymyositis","volume":"56","author":"Benveniste","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0520","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1111\/j.1365-2567.2008.03039.x","article-title":"Roles of proinflammatory cytokines and the Fas\/Fas ligand interaction in the pathogenesis of inflammatory myopathies","volume":"128","author":"Kondo","year":"2009","journal-title":"Immunology"},{"issue":"Pt 6","key":"10.1016\/j.bbadis.2014.05.034_bb0525","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/brain\/120.6.929","article-title":"Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells","volume":"120","author":"Behrens","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0530","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0535","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.20649","article-title":"Myeloid dendritic cells in inclusion-body myositis and polymyositis","volume":"35","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0540","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3899\/jrheum.120590","article-title":"Fascin-expressing dendritic cells dominate in polymyositis and dermatomyositis","volume":"40","author":"Gendek-Kubiak","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0545","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.1995.tb03587.x","article-title":"Local T-cell proliferation and differentiation in inflammatory myopathies","volume":"41","author":"Lindberg","year":"1995","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0550","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1002\/art.34551","article-title":"Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model","volume":"64","author":"Liao","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0555","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","article-title":"Differential expression of chemokines in inflammatory myopathies","volume":"58","author":"De Bleecker","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0560","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2012.11.064","article-title":"The nonnecrotic invaded muscle fibers of polymyositis and sporadic inclusion body myositis: on the interplay of chemokines and stress proteins","volume":"535","author":"De Paepe","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0565","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.146.11.3877","article-title":"Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains","volume":"146","author":"Reyes","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0570","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jdermsci.2013.06.014","article-title":"Administration of cathepsin B inhibitor CA-074Me reduces inflammation and apoptosis in polymyositis","volume":"72","author":"Feng","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0575","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/NEN.0b013e3181e10925","article-title":"Macrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathies","volume":"69","author":"Reimann","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0580","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/mus.23898","article-title":"Invasive fibroblasts: fundamental difference between sporadic inclusion body myositis and polymyositis","volume":"49","author":"Doppler","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0585","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q. J. Med."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0590","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00415-005-0683-5","article-title":"High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders","volume":"252","author":"Hengstman","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0595","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/PL00007850","article-title":"Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies","volume":"249","author":"Hengstman","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0600","first-page":"692","article-title":"Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations","volume":"16","author":"Hengstman","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0605","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","article-title":"Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres","volume":"68","author":"Mozaffar","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0610","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","article-title":"Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression","volume":"48","author":"Gunawardena","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0615","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2990.2012.01302.x","article-title":"Review: immune-mediated necrotising myopathies\u2014a heterogeneous group of diseases with specific myopathological features","volume":"38","author":"Stenzel","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0620","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.0b013e31829c5eb0","article-title":"Clinical reasoning: a 39-year-old woman with progressive proximal weakness","volume":"81","author":"Quinn","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0625","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0630","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0635","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotising myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0640","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1093\/emboj\/cdg337","article-title":"Structure, function and evolution of the signal recognition particle","volume":"22","author":"Nagai","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0645","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar1895","article-title":"Human autoantibodies against the 54kDa protein of the signal recognition particle block function at multiple stages","volume":"8","author":"Romisch","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0650","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2013.08.008","article-title":"Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotising myopathy (ASANM)","volume":"264","author":"Rojana-Udomsart","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0655","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11910-011-0232-9","article-title":"Update on toxic myopathies","volume":"12","author":"Mastaglia","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0660","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nmd.2013.09.011","article-title":"Statin myotoxicity: a review of genetic susceptibility factors","volume":"24","author":"Needham","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0665","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0670","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mcp.2001.120251","article-title":"Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin","volume":"70","author":"Mulder","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0675","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01213011-200506000-00007","article-title":"Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage","volume":"15","author":"Wilke","year":"2005","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0680","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/mus.22115","article-title":"Association of common variants in the human eyes shut ortholog (EYS) with statin-induced myopathy: evidence for additional functions of EYS","volume":"44","author":"Isackson","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0685","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.clpt.2005.08.003","article-title":"The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment","volume":"78","author":"Fiegenbaum","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0690","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1592\/phco.26.11.1601","article-title":"Role of P-glycoprotein in statin drug interactions","volume":"26","author":"Holtzman","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0695","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature12508","article-title":"A statin-dependent QTL for GATM expression is associated with statin-induced myopathy","volume":"502","author":"Mangravite","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0700","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/taap.1997.8131","article-title":"Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro","volume":"145","author":"Flint","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0705","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.05.021","article-title":"Molecular basis of statin-associated myopathy","volume":"202","author":"Vaklavas","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0710","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","article-title":"Effect of coenzyme q10 on myopathic symptoms in patients treated with statins","volume":"99","author":"Caso","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0715","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jns.2012.12.023","article-title":"Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy","volume":"325","author":"Stringer","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0720","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.ATV.0000190608.28704.71","article-title":"Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins","volume":"25","author":"Urso","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0725","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1113\/jphysiol.2008.164699","article-title":"Blunted Akt\/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy","volume":"587","author":"Mallinson","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0730","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5551\/jat.E551","article-title":"Investigation of gene expression in C(2)C(12) myotubes following simvastatin application and mechanical strain","volume":"16","author":"Yu","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0735","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotising myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0740","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0745","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kD and 100-kD proteins is associated with an immune-mediated necrotising myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0750","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","article-title":"Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0755","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","article-title":"Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Werner","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0760","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with up-regulation of MHC-I associated with statin therapy","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2014.05.034_bb0765","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mus.21479","article-title":"Skeletal muscle cell MHC I expression: implications for statin-induced myopathy","volume":"41","author":"Singh","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbadis.2014.05.034_bb0770","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/acr.21671","article-title":"Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T10:25:23Z","timestamp":1716805523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443914001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":154,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0925443914001628"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.05.034","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatomyositis, polymyositis and immune-mediated necrotising myopathies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}